Identification of New Antigenic Peptide Presented by HLA-Cw7 and Encoded by Several MAGE Genes Using Dendritic Cells Transduced with Lentiviruses

Journal of Immunology

Volumn 172, Issue 4, 2004, Pages 2232-2237

  Breckpot, Karine ^a   Heirman, Carlo ^a   De Greef, Catherine ^a   Van Der Bruggen, Pierre ^b   Thielemans, Kris ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b L Inst Cancer Res Brussels Br   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD8 ANTIGEN; GLUTAMYLGLYCYLASPARTYLCYSTEINYLALANYLPROLYLGLUTAMYLGLUTAMYLLYSINE; HLA C ANTIGEN; HLA CW7 ANTIGEN; LENTIVIRUS VECTOR; MAGE 12 PROTEIN; MAGE 6 PROTEIN; MELANOMA ANTIGEN; MELANOMA ANTIGEN 2; MELANOMA ANTIGEN 3; PEPTIDE; PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DNA MODIFICATION; DRUG TARGETING; GENE; GENE EXPRESSION; HLA SYSTEM; HUMAN; HUMAN CELL; LENTIVIRINAE; MAGE GENE; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENE; VIRUS RECOMBINANT;

EID: 0842321785     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.4.2232     Document Type: Article

References (36)

1. Boon, T., J. C. Cerottini, B. Van den Eynde, P. van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337.
2. Van der Bruggen, P., Y. Zhang, P. Chaux, V. Stroobant, C. Panichelli, E. S. Shultz, J. Chapiro, B. J. Van den Eynde, F. Brasseur, and T. Boon. 2002. Tumor-specific shared antigenic peptides recognized by human T cells, Immunol. Rev. 188:51.
3. Marchand, M., N. van Baren, P. Weynants, V. Brichard, B. Dreno, M. H. Tessier, E. Rankin, G. Parmiani, F. Arienti, Y. Humblet. et al. 1999. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer 80:219.
4. Marchand, M., V. Brichard. N. van Baren, and P. G. Coulie. 2001. Biological and clinical developments in melanoma vaccines. Exp. Opin. Biol. Ther. 1:497.
5. Thurner, B., I. Haendle, C. Roder, D. Dieckmann, P. Keikavoussi, H. Jonuleit, A. Bender. C. Maczek, D. Schreiner, P. von den Driesch, et al. 1999. Vaccination with MAGE-3AI peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190:1669.
6. Jager, D., E. Jager, and A. Knuth. 2001. Vaccination for malignant melanoma: recent developments. Oncology 60:1.
7. Fong, L., and E. G. Engleman. 2000. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18:245.
8. Kirk, C. J., and J. J. Mule. 2000. Gene-modified dendritic cells for use in tumor vaccines. Hum. Gene Ther. 11:797.
9. Jenne, L., G. Schuler, and A. Steinkasserer. 2001. Viral vectors for dendritic cell-based immunotherapy. Trends Immunol. 22:102.
10. Schroers, R., I. Sinha, H. Segall, I. G. Schmidt-Wolf. C. M. Rooney, M. K. Brenner, R. E. Sutton, and S. Y. Chen. 2000. Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol. Ther. 1:171.
11. Gruber. A., J. Kan-Mitchell, K. L. Kuhen, T. Mukai, and F. Wong-Staal. 2000. Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HlV-specific cytotoxic T-lymphocyte response in vitro. Blood 96:1327.
12. Chinnasamy, N., D. Chinnasamy, J. F. Toso, R. Lapointe, F. Candotti, R. A. Morgan, and P. Hwu. 2000. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors. Hum. Gene Ther. 11:1901.
13. Metharom, P., S. Takyar, H. Q. Xia, K. A. Ellem, G. E. Wilcox, and M. Q. Wei. 2001. Development of disabled, replication-defective gene transfer vectors from the Jembrana disease virus, a new infectious agent of cattle. Vet. Microbiol. 80:9.
14. Esslinger, C., P. Romero, and H. R. MacDonald. 2002. Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors. Hum. Gene Ther. 13:1091.
15. Firat, H., V. Zennou, F. Garcia-Pons, F. Ginhoux, M, Cochet, O, Danos, F. A. Lemonnier, P. Langlade-Demoyen, and P. Charneau. 2002, Use of a lentiviral flap vector for induction of CTL immunity against melanoma: perspectives for immunotherapy. J. Gene Med. 4:38.
16. Breckpot, K., M. Dullaers. A. Bonehill. S. van Meirvenne, C. Heirman, C. de Greef, P. van der Bruggen. and K. Thielemans. 2003. Lentivirally transduced dendritic cells as a tool for cancer immunotherapy. J. Gene Med. 5:654.
17. Dyall, J., J. B. Latouche. S. Schnell, and M. Sadelain. 2001. Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes. Blood 97:114.
18. Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotech. nol. 15:871.
19. Zufferey, R., T. Dull, R. J. Mandel, A. Bukovsky, D. Quiroz, L. Naldini, and D. Trono. 1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72:9873.
20. Zufferey, R., J. E. Donello, D. Trono, and T. J. Hope. 1999. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73:2886.
21. Follenzi, A., L. E. Ailles, S. Bakovic, M. Geuna, and L. Naldini. 2000. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25:217.
22. Miyoshi, H., U. Blomer. M. Takahashi, F. H. Gage, and I. M. Verma. 1998. Development of a self-inactivating lentivirus vector. J. Virol. 72:8150.
23. Zennou, V., C. Petit, D. Guetard, U. Nerhbass, L. Montagnier, and P. Charneau. 2000. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101:173.
24. Gaugler, B., B. Van den Eynde, P. van der Bruggen, P. Romero, J. J. Gaforio, E. De Plaen, B. Lethe, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921.
25. Kocher, T., E. Schultz-Thater, F. Gudat, C. Schaefer, G. Casorati, A. Juretic, T. Willimann, F. Harder, M. Heberer, and G. C. Spagnoli. 1995. Identification and intracellular location of MAGE-3 gene product. Cancer Res. 55:2236.
26. + cytolytic T lymphocytes. Cancer Res. 60:6272.
27. Sanderson, S., K. Frauwirth, and N. Shastri. 1995. Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins. Proc. Natl. Acad. Sci. USA 92:7217.
28. Jonuleit, H., U. Kuhn, G. Muller, K. Steinbrink, L. Paragnik, E. Schmitt, J. Knop, and A. H. Enk. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serumfree conditions. Eur. J. Immunol. 27:3135.
29. + T lymphocytes. J. Exp. Med. 189:767.
30. Skipper, P. L. 1996. Influence of tertiary structure on nucleophilic substitution reactions of proteins. Chem. Res. Toxicol. 9:918.
31. Meadows, L., W. Wang, J. M. den Haan, E. Blokland. C. Reinhardus, J. W. Drijfhout, J. Shabanowitz, R. Pierce, A. I. Agulnik, C. E. Bishop, et al. 1997. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 6:273.
32. Schultz, E. S., Y. Zhang, R. Knowles, J. Tine, C. Traversari, T. Boon, and P. van der Bruggen. 2001. A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes. Tissue Antigens 57:103.
33. Luiten, R. M., N. Demotte, J. Tine, and P. van der Bruggen. 2000. A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules. Tissue Antigens 56:77.
34. Falk, K., O. Rotzschke, B. Grahovac, D. Schendel, S. Stevanovic. V. Gnau, G. Jung, J. L. Strominger, and H. G. Rammensee. 1993. Allele-specific peptide ligand motifs of HLA-C molecules. Proc. Natl. Acad. Sci., USA 90:12005.
35. Chaux, P., R. Luiten, N. Demotte, V. Vantomme, V. Stroobant. C. Traversari, V. Russo, E. Schultz, G. R. Cornelis, T. Boon, and P. van der Bruggen. 1999. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. J. Immunol. 163:2928.
36. Marsh, G. E. S., P. P. Parham, and D. L. Barber. 2000. Cw*07-Cw7. In The HLA Facts Book. Academic Press, New York, p. 257.